Hostname: page-component-76fb5796d-qxdb6 Total loading time: 0 Render date: 2024-04-26T20:46:15.325Z Has data issue: false hasContentIssue false
  • English
  • Français

Plasma total glutathione in humans and its association with demographic and health-related factors

Published online by Cambridge University Press:  02 April 2007

Elaine W. Flagg ,
Ralph J. Coates ,
Dean P. Jones ,
J. William Eley ,
Elaine W. Gunter ,
Bethany Jackson  and
Raymond S. Greenberg
Elaine W. Flagg
Affiliation:
Division of Epidemiology, Emory University School of Public Health, Atlanta, Georgia, USA
Ralph J. Coates
Affiliation:
Division of Epidemiology, Emory University School of Public Health, Atlanta, Georgia, USA
Dean P. Jones
Affiliation:
Department of Biochemistry, Emory University School of Medicine, Atlanta, Georgia, USA
J. William Eley
Affiliation:
Division of Epidemiology, Emory University School of Public Health, Atlanta, Georgia, USA Winship Cancer Center, Emory University School of Medicine, Atlanta, Georgia, USA
Elaine W. Gunter
Affiliation:
Nutritional Biochemistry Branch, Division of Environmental Health Laboratory Sciences, Center for Environmental Health and Injury Control, Centers for Disease Control, Atlanta, Georgia, USA
Bethany Jackson
Affiliation:
Department of Nutrition and Family Studies, Andrews University, Berrien Springs, Michigan, USA
Raymond S. Greenberg
Affiliation:
Division of Epidemiology, Emory University School of Public Health, Atlanta, Georgia, USA
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The tripeptide glutathione is proposed to be protective against a number of chronic diseases including cardiovascular disease and cancer. However, there have been few studies of plasma glutathione levels in humans and in those studies the numbers of participants have been very small. In an exploratory analysis the determinants of plasma total glutathione (GSHt) were investigated in a group of 100 volunteers aged 18–61 years in Atlanta, Georgia, USA during June and July 1989. Data on demographic and health-related factors were collected by interview and plasma GSHt was measured using a recently modified laboratory method. The mean concentration of plasma GSHt for all 100 participants was 761 μg/l, with a standard deviation of 451 μg/l, a range of 86–2889 μg/1 and a median of 649 μg/l. Men had significantly higher levels of plasma GSHt than women (924 v. 692 μg/l; P = 0·006). Seventh-day Adventists participating in the present study had higher plasma GSHt levels than other subgroups defined by race and/or religion. Among Seventh-day Adventists consumption of a vegetarian diet was associated with increased plasma GSHt concentration (P = 0·002). Plasma GSHt levels also appeared to vary by race, but relationships with race could not be clearly disassociated from relationships with religion. Among white participants plasma GSHt concentration decreased with age in women but increased with age in men (P = 0·05). Few other factors were associated with plasma GSHt concentration, although use of oral contraceptives (P = 0·10) was somewhat associated with decreased plasma GSHt levels. These findings suggest that plasma GSHt levels may vary with several demographic and health-related attributes and support the need for further research on this potentially important disease-preventive compound.

Keywords

Plasma glutathioneDisease preventionHumans
Type
Demographic and Health-related Factors, and Plasma Glutathione
Information
British Journal of Nutrition , Volume 70 , Issue 3 , November 1993 , pp. 797 - 808
Copyright
Copyright © The Nutrition Society 1993

References

REFERENCES

Ames, B. N. (1983). Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases. Science 221, 1256–1264.CrossRefGoogle ScholarPubMed
Aw, T. Y., Wierzbicka, G. & Jones, D. P. (1991). Oral glutathione increases tissue glutathione in vivo. Chemico-Biological Interactions 80, 89–97.CrossRefGoogle ScholarPubMed
Beeson, W. L., Mills, P. K., Phillips, R. L., Andress, M. & Fraser, G. E. (1989). Chronic disease among Seventh-day Adventists, a low-risk group. Rationale, methodology, and description of the population. Cancer 64, 570–581.3.0.CO;2-4>CrossRefGoogle ScholarPubMed
Bendich, A. (1990). Antioxidant micronutrients and immune responses. Annals of the New York Academy of Sciences 587, 168–180.CrossRefGoogle ScholarPubMed
Beutler, E. & Gelbart, T. (1985). Plasma glutathione in health and in patients with malignant disease. Journal of Laboratory and Clinical Medicine 105, 581–584.Google ScholarPubMed
Block, G. (1989). Health Habits and History Questionnaire: Diet History and Other Risk Factors. Personal Computer System Packet. Bethesda, Maryland: Division of Cancer Prevention and Control, US National Cancer Institute, US National Institutes of Health.Google Scholar
Bounous, G., Gervais, F., Amer, V., Batist, G. & Gold, P. (1989). The influence of dietary whey protein on tissue glutathione and the diseases of aging. Clinical and Investigative Medicine 12, 343–349.Google ScholarPubMed
Buhl, R., Holroyd, K. J., Mastrangeli, A., Cantin, A. M., Jaffe, H. A., Wells, F. B., Saltini, C. & Crystal, R. G. (1989). Systemic gluthatione deficiency in symptom-free HIV-seropositive individuals. Lancet ii 1294–1298.CrossRefGoogle Scholar
Burgunder, J. M. & Lauterburg, B. H. (1986). Plasma kinetics of glutathione (GSH) in man: a non-invasive probe to assess hepatic GSH production. Gastroenterology 90, 1717 Abstr.Google Scholar
Calcutt, G. (1967). Diurnal variations in rat blood glutathione levels. Naturwissenschaften 54, 120.CrossRefGoogle ScholarPubMed
Cerutti, P. A. (1985). Prooxidant states and tumor promotion. Science 227, 375–381.CrossRefGoogle ScholarPubMed
Chawla, R. K., Lewis, F. W., Kutner, M. H., Bate, D. M., Roy, R. G. B. & Rudman, D. (1984). Plasma cysteine, cystine, and glutathione in cirrhosis. Gastroenterology 87, 770–776.CrossRefGoogle ScholarPubMed
Cross, C.E., Halliwell, B.Borish, E. T., Pryor, W. A., Ames, B. N., Saul, R. L., McCord, J. M. & Harman, D. (1987). Davis conference. Oxygen radicals and human disease. Annals of Internal Medicine 107, 526–545.CrossRefGoogle Scholar
Droge, W., Pottmeyer-Gerber, C., Schmidt, H. & Nick, S. (1986). Glutathione augments the activation of cytotoxic T lymphocytes in vivo. Immunobiology 172, 151–156.CrossRefGoogle ScholarPubMed
Dwyer, J. T. (1988). Health aspects of vegetarian diets. American Journal of Clinical Nutrition 48, 712–738.CrossRefGoogle ScholarPubMed
Flanders, W. D., DerSimonian, R. & Freedman, D. S. (1992). Interpretation of linear regression models that include transformations or interaction terms. Annals of Epidemiology 2, 735–744.CrossRefGoogle ScholarPubMed
Frei, B., England, L. & Ames, B. N. (1989). Ascorbate is an outstanding antioxidant in human blood plasma. Proceedings of the National Academy of Sciences of the U.S.A. 86, 6377–6381.CrossRefGoogle ScholarPubMed
Hagen, T. M. & Jones, D. P. (1987). Transepithelial transport of glutathione in vascularly perfused small intestine of rat. American Journal of Physiology 252, G607–G613.Google ScholarPubMed
Hagen, T. M. & Jones, D. P. (1989). Role of glutathione transport in extrahepatic detoxication. In Glutathione Centennial: Molecular Perspectives and Clinical Implications pp. 423–433 [Sakamoto, Y.Higashi, T.Taniguchi, N. and Meister, A., editors]. San Diego, California: Academic Press.CrossRefGoogle Scholar
Hagen, T. M., Wierzbicka, G. T., Sillau, A. H., Bowman, B. B. & Jones, D. P. (1990). Bioavailability of dietary glutathione: effect on plasma concentration. American Journal of Physiology 259, G524–G529.Google ScholarPubMed
Hagenfeldt, L., Arvidsson, A. & Larsson, A. (1978). Glutathione and gamma-glutamylcysteine in whole blood, plasma and erythrocytes. Clinica Chimica Acta 85, 167–173.CrossRefGoogle Scholar
Hamilos, D. L. & Wedner, H. J. (1985). The role of glutathione in lymphocyte activation. I. Comparison of inhibitory effects of buthionine sulfoximine and 2-cyclohexene- I-one by nuclear size transformation. Journal of Immunology 135, 2140–2747.Google Scholar
Hazelton, G. A. & Lang, C. A. (1980). Glutathione contents of tissues in the aging mouse. Biochemical Journal 188, 25–30.CrossRefGoogle ScholarPubMed
Henning, S. M., Zhang, J. Z., McKee, R. W., Swendseid, M. E. & Jacob, R. A. (1991). Glutathione blood levels and other oxidant defense indices in men fed diets low in vitamin C. Journal of Nutrition 121, 1969–1975.CrossRefGoogle ScholarPubMed
Hirayama, K., Yasutake, A. & Inoue, M. (1987). Effect of sex hormones on the fate of methylmercury and on glutathione metabolism in mice. Biochemical Pharmacology 36, 1919–1924.Google ScholarPubMed
Hunter, D. (1990). Biochemical indicators of dietary intake. In Nutritional Epidemiology pp. 143–216 [Willett, W. editor]. New York, NY: Oxford University Press.Google Scholar
Jones, D. P., Coates, R. J., Flagg, E. W., Eley, J. W., Block, G., Greenberg, R. S., Gunter, E. W. & Jackson, B. (1992). Glutathione in foods listed in the National Cancer Institute's health habits and history food frequency questionnaire. Nutrition and Cancer 17, 57–75.CrossRefGoogle ScholarPubMed
Lash, L. H. & Jones, D. P. (1985). Distribution of oxidized and reduced forms of glutathione and cysteine in rat plasma. Archives of Biochemistry and Biophysics 240, 583–592.CrossRefGoogle ScholarPubMed
Lauterburg, B. H., Adams, J. D. & Mitchell, J. R. (1984 a). Hepatic glutathione homeostasis in the rat: efflux accounts for glutathione turnover. Hepatology 4, 586–590.CrossRefGoogle ScholarPubMed
Lauterburg, B. H. & Mitchell, J. R. (1981). Regulation of hepatic glutathione turnover in rats in vivo and evidence for kinetic homogeneity of the hepatic glutathione pool. Journal of Clinical Investigation 67, 1415–1424.CrossRefGoogle ScholarPubMed
Lauterburg, B. H., Velez, M. E. & Mitchell, J. R. (1984 b). Plasma glutathione (GSH) as an index of intrahepatic GSH in man: response to acetaminophen (AP) and chronic ethanol abuse. Hepatology 4, 1051 Abstr.Google Scholar
Meister, A. (1989). Metabolism and function of glutathione. In Glutathione. Chemical, Biochemical, and Medical Aspects, part A, pp. 367–474 [Dolphin, D., Avramovic, O. and Poulson, R., editors]. New York, New York: John Wiley and Sons.Google Scholar
National Research Council Committee on Diet and Health (1989). Diet and Health: Implications, for Reducing Chronic Disease Risk pp. 210, 212, 278–279. Washington D. C.: National Academy Press.Google Scholar
Neter, J., Wasserman, W. & Kutner, M. H. (1985). Applied Linear Statistical Models. Regression, Analysis of Variance, and Experimental Designs, 2nd ed. Homewood, Illinois: Richard D. Irwin, Inc.Google Scholar
Owens, C. W. I. & Belcher, R. V. (1965). A colorimetric micro-method for the determination of glutathione. Biochemical Journal 94, 705–711.CrossRefGoogle ScholarPubMed
Phillips, R. L. (1975). Role of life-style and dietary babits in risk of cancer among Seventh-day Adventists. Cancer Research 35, 3513–3522.Google Scholar
Phillips, R. L., Lemon, F. R., Beeson, W. L. & Kuzma, J. W. (1978). Coronary heart disease mortality among Seventh-day Adventists with differing dietary habits: a preliminary report. American Journal of Clinical Nutrition 31, S191–S198.CrossRefGoogle ScholarPubMed
Reed, D. J., Babson, J. R., Beatty, P. W., Brodie, A. E., Ellis, W. W. & Potter, D. W. (1980). High-performance liquid chromatography analysis of nanomole levels of glutathione, glutathione disulfide, and related thiols and disulfides. Analytical Biochemistry 106, 55–62.CrossRefGoogle ScholarPubMed
Sendelbach, L. E., White, C. A., Howell, S., Gregus, Z. & Klaassen, C. D. (1990). Effect of sulfhydryl-deficient diets on hepatic metallothionein, glutathione, and adenosine 3'-phosphate 5'-phosphosulfate (PAPS) levels in rats. Toxicology and Applied Pharmacology 102, 259–267.CrossRefGoogle ScholarPubMed
Shan, X., Aw, T. Y. & Jones, D. P. (1990). Glutathione-dependent protection against oxidative injury. Pharmacology and Therapeutics 41, 61–71.CrossRefGoogle Scholar
Stevens, J. L. & Jones, D. P. (1989). The mercapluric acid pathway: biosynthesis, intermediary metabolism, and physiological disposition. In Glutathione. Chemical, Biochemical, and Medical Aspects, part B, pp. 45–84 [Dolphin, D., Avramovic, O. and Poulson, R., editors]. New York, New York: John Wiley and Sons.Google Scholar
Stohs, S. J., Al-Turk, W. A. & Angle, C. R. (1982). Glutathione S-transferase and glutathione reductase activities in hepatic and extrahepatic tissues of female mice as a function of age. Biochemical Pharmacology 31, 2113–2116.CrossRefGoogle ScholarPubMed
Taniguchi, M., Hirayama, K., Yamaguchi, K., Tateishi, N. & Suzuki, M. (1989). Nutritional aspects of glutathione metabolism and function. In Glutathione, Chemical. Biochemical, and Medical Aspects, part B, pp. 645–727 [Dolphin, D., Avramovic, O. and Poulson, R., editors]. New York, New York: John Wiley and Sons.Google Scholar
Wefers, H. & Sies, H. (1988). The protection by ascorbate and glutathione against microsomal lipid peroxidation is dependent on vitamin E. European Journal of Biochemistry 174, 353–357.CrossRefGoogle ScholarPubMed
Wendel, A. & Cikryt, P. (1980). The level and half-life of glutathione in human plasma. FEBS Letters 120, 209–211.CrossRefGoogle ScholarPubMed
Zar, J. H. (1984). Biostatistical Analysis. 2nd ed. Englewood Cliffs, New Jersey: Prentice-Hall, Inc.Google Scholar